[Federal Register: September 15, 2009 (Volume 74, Number 177)]
[Notices]
[Page 47262]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15se09-101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine
Effectiveness for Preventing Laboratory Confirmed Influenza in the
United States, Funding Opportunity Announcement (FOA) IP08-00101SUPP10,
Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 10 a.m.-11 a.m., September 25, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of ``Annual Estimates of
Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed
Influenza in the United States, FOA IP08-00101SUPP10.''
Contact Person for More Information: Gregory Anderson, M.P.H.,
M.S., CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333,
Telephone: (404) 498-2275.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 4, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-22154 Filed 9-14-09; 8:45 am]
BILLING CODE 4163-18-P